Evotec – Talk Bio

Actionable Insights Powered by AI

Halozyme Therapeutics Abandons $2.1 Billion Acquisition Bid for Evotec Due to Lack of Engagement

5 months ago talkbio0Tagged Acquisition, Evotec, Halozyme, Industry, Twice a day, Withdraw (activity)

Halozyme Therapeutics, Evotec, acquisition bid, withdrawal, lack of engagement, biotech industry

Evotec Shares Soar as Private Equity Firm Triton Considers Takeover Bid

5 months ago talkbio0Tagged Drug Development, Evotec, Partner in relationship, Private Equity, Triton - satellite of Neptune, Twice a day

Evotec, Triton Partners, takeover bid, private equity, drug development, pharmaceuticals

Evotec Announces Restructuring Plan Amid Research Spending Slowdown

8 months ago talkbio0Tagged Biopharma, Evotec, gene therapy, research, restructuring

Evotec, layoffs, restructuring, research spending slowdown, gene therapy, biopharma

Evotec Announces 400 Job Cuts Amid Market Challenges

8 months ago talkbio0Tagged Challenge, Contract agreement, development aspects, Drug Discovery, Evotec, Manufacture, Market, restructuring

Evotec, job cuts, market challenges, restructuring, drug discovery, contract development, manufacturing

Evotec Discontinues Gene Therapy Operations, Shuts Down Austria Facility

11 months ago talkbio0Tagged Austria, Biotechnology, business operations, development aspects, Evotec, Facility (object), gene therapy, Reparative closure, research, strategic decision

Evotec, gene therapy, Austria, facility closure, strategic decision, business operations, research and development, biotechnology